Nordson Corporation reported a 5% increase in sales to $719 million and a record EBITDA of $227 million for the fourth quarter of fiscal year 2023. The company's performance was driven by strong growth in medical interventional solutions, industrial coatings, and polymer processing product lines, which offset weakness in electronics dispense and biopharma product lines. Adjusted earnings per diluted share were $2.46, compared to $2.44 in the prior year.